CRNX Dec 2024 30.000 put
| Previous Close | 2.0000 |
| Open | 2.0000 |
| Bid | 0.0000 |
| Ask | 2.7500 |
| Strike | 30.00 |
| Expire Date | 2024-12-20 |
| Day's Range | 2.0000 - 2.0000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 10 |
GlobeNewswireCrinetics Pharmaceuticals Announces Early Release of ENDO 2024 Late-Breaking Abstracts
SAN DIEGO, May 22, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors, today announced that the late-breaking abstracts accepted for presentation at the Endocrine Society’s annual meeting (ENDO 2024) were released earlier than the previously announced embargoed date. The abstract for the Phase 2, open-la
Insider MonkeyCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2024 Earnings Call Transcript
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2024 Earnings Call Transcript May 11, 2024 Crinetics Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Crinetics Pharmaceuticals First Quarter 2024 Earnings Conference Call. At this time, all participants are […]
Simply Wall St.Investors in Crinetics Pharmaceuticals (NASDAQ:CRNX) have seen solid returns of 196% over the past three years
It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...
